Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Víctor Javier Sánchez-Arévalo Lobo"'
Autor:
Raúl Muñoz Velasco, Paula Jiménez Sánchez, Ana García García, Raquel Blanco Martinez-Illescas, Ángela Pastor Senovilla, Marian Lozano Yagüe, Alfonsina Trento, Rosa María García-Martin, Diego Navarro, Bruno Sainz, José Luis Rodríguez Peralto, Víctor Javier Sánchez-Arévalo Lobo
Publikováno v:
DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria
instname
Cancers; Volume 14; Issue 6; Pages: 1518
instname
Cancers; Volume 14; Issue 6; Pages: 1518
Pancreatic ductal adenocarcinoma (PDA) is characterized by an extremely poor prognosis due to its late diagnosis and strong chemoresistance to the current treatments. Therefore, finding new therapeutic targets is an urgent need nowadays. In this stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c243dccefb08d60892789f9ebaff55b
http://hdl.handle.net/10261/291112
http://hdl.handle.net/10261/291112
Autor:
Raúl Muñoz Velasco, Ana García García, Paula Jiménez Sánchez, Inmaculada Montanuy Sellart, Víctor Javier Sánchez-Arévalo Lobo
Publikováno v:
Journal of physiology and biochemistryReferences.
Pancreatic ductal adenocarcinoma (PDA) is a disease with a survival rate of 9%; this is due to its chemoresistance and the large tumour stroma that occupies most of the tumour mass. It is composed of a large number of cells of the immune system, such
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::276bfada7b0066656e123cd733dcc900
https://pubmed.ncbi.nlm.nih.gov/35102531
https://pubmed.ncbi.nlm.nih.gov/35102531
